Abstract:Abstract OBJECTIVE Dendritic cells (DCs) are important functional antigen-presenting cells that play an essential role in initiating and modulating immune responses. Their mature states are crucial for the induction of T-cell-mediated immune reactions. Therefore, The mechanism of T cell anergy related with DCs and research in applying immature DCs to establish donor-specific immune tolerance have become one of the new frontiers in the field of transplantation immunity. The activation of nuclear factor kappa B(NF-κB) has been said to modulate the maturation of DCs, which controls the transcription of genes encoding major histocompatibility complex(MHC)antigens, and costimulator molecules for T cell activation. The CD47 Ag, a multispan transmembrane ptotein expressed on all hemopoietic cells, has an immunosuppressive function with its ligand, monoclonal antibody (mAb) or thrombospondin. In the current study, we investigate the influence of CD47 engagement by its soluble mAb B6H12 on the maturation and function of cultured DCs. Further to observe any results could be ascribed to the effect of B6H12 mAb on the nuclear translocation and DNA binding of NF-κB. METHODS Monocyte-derived DCs were propagated in granulocyte-macrophage colony stimulating factor (GM-CSF) combined with lipopolysaccharide (LPS) and interleukin(IL)-4, in the presence or absence of soluble anti-CD47 monoclonal antibodies (anti-CD47 mAbs, B6H12). The phenotype of DCs(CD80, CD86, CD83, CD1a, HLA-DR) were detected by the flow cytometry. Semi-quantitative RT-PCR and ELISA methods were used to analyse the mRNA and protein expression levels of interleukin-12(IL-12). The antigen-presenting functions of DCs were determined in one-way mixed leukocyte reaction by Brdu-ELISA. Electrophoretic mobility shift assay (EMSA) was applied to examine the activity of NF-κB. RESULTS Both the immature and the mature DCs express CD47, which has a ratio of 94-98%. The cell immune phenotype was lower in B6H12 mAb treated DC group than that in untreated groups. The data were as follow:CD80+(68.14±7.41)% vs (89.17±8.59)%; CD86+ (67.33±4.71)% vs (87.27±3.56)%;CD83(40.08±14.80)% vs (72.77±8.68)%;Cdla+(66.45±4.06)% vs (95.93±3.03)%; HLA-DR(40.67±13.48) vs (98.97±1.01)%, respectively. The mRNA levels of IL-12 P40 was decreased (P<0.01) with the treatment of B6H12 mAb. Pre-exposure of developing DCs to 10μg/ml B6H12 considerably reduced their subsequent ability to secret IL-12 P70 upon stimulation by LPS, comparing with the other two control groups [(36.6±3.83)pg/ml vs (80.43±8.24)pg/ml vs(83.7±9.58 )pg/ml] (P<0.05). It is also noted that the inhibition of IL-12 P70 release by B6H12 mAb was dependent on dose at the range of 2.5 - 10μg/ml, and the inhibition can be seen in DCs treated with B6H12 mAb at the dose of 2.5μg/ml. The data of the mixed leukocyte reaction were consistent with the flow cytometry results (P<0.01). Pre-exposure to B6H12 mAb during the development of DCs resulted in a dramatic decrease of the DNA binding activity toward protein in the nucleus. Moreover, this inhibition was also seemed to be dose dependent (2.5μg/ml, 5μg/ml, 10μg/ml) and the density scan values were:126.1±4.32, 103.46±10.96, 72.80±10.08. CONCLUSION This results indicate that the CD47 ligation by B6H12 mAb exerts a negative effect on the maturation and function of in vitro cultured DCs through the inhibition of NF-κB binding activity, which suggest its favorable role in the induction of modulation of immune tolerance.

The role of B7 molecules in T cell anergy

[The Identical Effects of B7-1 and B7-2 on Regulation of Human IL-2 Gene Transcription Factors NF-kappa B and AP-1].

Differential Involvement of Α4β2, Α7 and Α9α10 Nicotinic Acetylcholine Receptors in B Lymphocyte Activation in Vitro

Engagement of B7 on Effector T Cells by Regulatory T Cells Prevents Autoimmune Disease.

Essential Roles Of Tgf-Beta In Anti-Cd3 Antibody Therapy: Reversal Of Diabetes In Nonobese Diabetic Mice Independent Of Foxp3(+) Cd4(+) Regulatory T Cells

High-Level Expression Of B7-H1 Molecules By Dendritic Cells Suppresses The Function Of Activated T Cells And Desensitizes Allergen-Primed Animals

Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig

Differential Susceptibility of Naïve Versus Cloned CD4+ T Cells to Antigen-Specific and MHC-restricted Anergy Induction.

Effect of Mycophenolic Acid on T Lymphocyte Proliferation and Cytokine Expression in Vitro

T-cell tolerance or function is determined by combinatorial costimulatory signals.

A molecular basis for T cell suppression by IL‐10: CD28‐associated IL‐10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3‐kinase binding

Mechanisms of NKT Cell Anergy Induction Involve Cbl-b-promoted Monoubiquitination of CARMA1

Establishing an evaluation system for T cell activation and anergy based on CD25 expression levels as an indicator

Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.

Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCs

CD47 Engagement Impairs the Function and Maturation of Human Dendritic Cells Via the Inhibition of NF-κB Avtivity.

Interaction of Cd5 and Cd72 is Involved in Regulatory T and B Cell Homeostasis

Inhibition of Th2-mediated allergic airway inflammatory disease by CD137 costimulation

Differential effect of anti-B7-1 and anti-M150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages.

Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8+ T Cells

Mechanism of IL-10-Induced T Cell Inactivation in Allergic Inflammation and Normal Response to Allergens